A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen - PubMed (original) (raw)
A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen
A Hameg et al. J Immunol. 2000.
Abstract
In the present report, we characterize a novel T cell subset that shares with the NKT cell lineage both CD1d-restriction and high reactivity in vivo and in vitro to the alpha-galactosylceramide (alpha-GalCer) glycolipid. These cells preferentially use the canonical Valpha14-Jalpha281 TCR-alpha-chain and Vbeta8 TCR-beta segments, and are stimulated by alpha-GalCer in a CD1d-dependent fashion. However, in contrast to classical NKT cells, they lack the NK1.1 marker and express high surface levels of CD1d molecules. In addition, this NK1.1(-) CD1d(high) T subset, further referred to as CD1d(high) NKT cells, can be distinguished by its unique functional features. Although NK1.1(+) NKT cells require exogenous CD1d-presenting cells to make them responsive to alpha-GalCer, CD1d(high) NKT cells can engage their own surface CD1d in an autocrine and/or paracrine manner. Furthermore, in response to alpha-GalCer, CD1d(high) NKT cells produce high amounts of IL-4 and moderate amounts of IFN-gamma, a cytokine profile more consistent with a Th2-like phenotype rather than the Th0-like phenotype typical of NK1.1(+) NKT cells. Our work reveals a far greater level of complexity within the NKT cell population than previously recognized and provides the first evidence for T cells that can be activated upon TCR ligation by CD1d-restricted recognition of their ligand in the absence of conventional APCs.
Similar articles
- Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M, Cantarella D, Schümann J, Naidenko OV, Garavaglia C, Beermann F, Kronenberg M, Dellabona P, MacDonald HR, Casorati G. Capone M, et al. J Immunol. 2003 Mar 1;170(5):2390-8. doi: 10.4049/jimmunol.170.5.2390. J Immunol. 2003. PMID: 12594262 - CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M, Faizunnessa NN, Wang CR, Cardell S. Sköld M, et al. J Immunol. 2000 Jul 1;165(1):168-74. doi: 10.4049/jimmunol.165.1.168. J Immunol. 2000. PMID: 10861049 - CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ, Pellicci DG, Poulton LD, Naidenko OV, Scalzo AA, Baxter AG, Godfrey DI. Hammond KJ, et al. J Immunol. 2001 Aug 1;167(3):1164-73. doi: 10.4049/jimmunol.167.3.1164. J Immunol. 2001. PMID: 11466330 - Regulation of immune responses by CD1d-restricted natural killer T cells.
Van Kaer L. Van Kaer L. Immunol Res. 2004;30(2):139-53. doi: 10.1385/IR:30:2:139. Immunol Res. 2004. PMID: 15477656 Review. - Application of natural killer T cells in antitumor immunotherapy.
Hong C, Park SH. Hong C, et al. Crit Rev Immunol. 2007;27(6):511-25. doi: 10.1615/critrevimmunol.v27.i6.20. Crit Rev Immunol. 2007. PMID: 18197797 Review.
Cited by
- Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer.
Horinaka A, Sakurai D, Ihara F, Makita Y, Kunii N, Motohashi S, Nakayama T, Okamoto Y. Horinaka A, et al. Cancer Sci. 2016 Mar;107(3):207-16. doi: 10.1111/cas.12866. Epub 2016 Feb 13. Cancer Sci. 2016. PMID: 26679292 Free PMC article. - Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection.
Emoto M, Yoshizawa I, Emoto Y, Miamoto M, Hurwitz R, Kaufmann SH. Emoto M, et al. Infect Immun. 2006 Oct;74(10):5903-13. doi: 10.1128/IAI.00311-06. Infect Immun. 2006. PMID: 16988270 Free PMC article. - Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.
Yang Q, Stevenson HL, Scott MJ, Ismail N. Yang Q, et al. Am J Pathol. 2015 Feb;185(2):446-61. doi: 10.1016/j.ajpath.2014.10.005. Epub 2014 Dec 4. Am J Pathol. 2015. PMID: 25481711 Free PMC article. - Invariant NKT Cell Lines Derived from the NOD·H2 Mouse Enhance Autoimmune Thyroiditis.
Sharma RB, Fan X, Caturegli P, Rose NR, Burek CL. Sharma RB, et al. J Thyroid Res. 2011;2011:895923. doi: 10.4061/2011/895923. Epub 2011 Apr 10. J Thyroid Res. 2011. PMID: 21603172 Free PMC article. - Intracellular bacterial infection and invariant NKT cells.
Emoto M, Emoto Y. Emoto M, et al. Yonsei Med J. 2009 Feb 28;50(1):12-21. doi: 10.3349/ymj.2009.50.1.12. Epub 2009 Feb 24. Yonsei Med J. 2009. PMID: 19259343 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous